Video Experimental Relacionado
Updated: Feb 26, 2026
11:17
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
13.5K
Impacto clínico potencial de las intervenciones farmacéuticas en un programa interprofesional de gestión de la
Christiane Eickhoff1, Ann Kathrin Strunz1, Maike Petersen1
1Department of Medicine, ABDA - Federal Union of German Associations of Pharmacists, Berlin, Germany.
Exploratory research in clinical and social pharmacy
|February 25, 2026
Resumen
El programa ARMIN, que combina revisiones de medicación y gestión continua, redujo el riesgo de mortalidad al abordar problemas relacionados con los medicamentos a través de intervenciones farmacéuticas. La colaboración eficaz entre farmacéuticos comunitarios y médicos fue clave para una gestión exitosa de la medicación.
Área de la Ciencia:
- Atención farmacéutica; Seguridad de la medicación; Investigación de servicios de salud
Sus antecedentes:
- Las revisiones de medicación (MR) y la gestión continua de la medicación (MM) mejoran la seguridad del paciente.; El programa interprofesional ARMIN MM redujo significativamente el riesgo de mortalidad.; Comprender el papel de las intervenciones farmacéuticas (PI) y la comunicación médica es crucial para el éxito de MM.
Objetivo del estudio:
- Investigar las intervenciones farmacéuticas (PI) de las farmacias comunitarias dentro del programa ARMIN.; Evaluar los tipos de problemas relacionados con los medicamentos (DRP) identificados y resueltos.; Evaluar el impacto clínico y económico de las PIs y la participación del médico.
Principales métodos:
- Estudio de intervención con diseño pre-post.; Período de observación de aproximadamente 6 meses por paciente.; Se evaluaron DRPs, PIs, cambios en la medicación, impacto clínico/económico y comunicación médica.
Principales resultados:
- 420 DRPs identificados inicialmente, 50 durante MM; 538 PIs realizadas.; Todos los pacientes experimentaron cambios en la medicación; el 76% de las PIs se implementaron con éxito.; Las PIs tuvieron un impacto clínico menor a moderado; la mayoría no tuvo efecto en los costos. El contacto con el médico se produjo en el 42,2% de las PIs.
Conclusiones:
- ARMIN resolvió con éxito los DRPs a través de PIs, lo que llevó a cambios en la medicación e impacto clínico.; La implementación exitosa de PIs resalta la importancia de la colaboración interprofesional y las responsabilidades definidas.; Los programas de gestión continua de la medicación requieren sólidas alianzas entre farmacéuticos comunitarios y médicos.
Videos de Conceptos Relacionados
01:26Pharmaceutical Poisoning: Potential Scenarios
37
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
37
01:25Pharmacokinetics: Drug–Drug Interactions
532
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
532
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
52
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
52
01:15Drug Dosing: Geriatric Patients
321
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
321
01:29Therapeutic Drug Monitoring: Affecting Factors
283
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
283
01:28Drug Therapy
322
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
322